Small team, specialized Real Time Genomics operates with a lean team (2-10 employees), signaling a potential need for scalable, outsourced collaboration, channel partnerships, or white-label solutions to support growth without a large internal headcount.

NGS analytics focus The company offers complete analytic platforms for genomics and metagenomics across next-generation sequencing workflows, presenting opportunities to upsell cloud-based processing, data management, or cross-platform integration with existing NGS pipelines.

Cloud and on-prem Solutions can be installed in customer compute environments or accessed via cloud computing, signaling a sales angle around hybrid deployment strategies, data governance, and scalable compute pricing for diverse customer IT setups.

Clinical progression Past collaboration with TOMA Biosciences on clinical-grade analysis tools and liquid biopsy applications suggests a ready path for life sciences and oncology customers seeking validated analytics for tumor and circulating tumor DNA workflows.

Growth signals Recurring RTG Core releases and steady press mentions imply ongoing product development and market validation, creating opportunities for customers needing up-to-date analytics, training, and support contracts to ensure adoption and ROI.